Rating History for Amylin Pharmaceuticals (AMLN) by Morgan Stanley

More Stocks Rated by Morgan Stanley | Latest Ratings for AMLN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/3/2012 N/A Upgrade Equalweight
(Underweight)		 N/A
(N/A)		 30.71
(30.98)		 0.88% Details